Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Novartis AG NVS

Healthcare Drug Manufacturers - Major
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and... see more

Current News (NYSE:NVS)

Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)

PR Newswire September 30, 2025

Argo Biopharma Announces Multi-Asset License and Option Agreements with Novartis for Novel Molecules for Cardiovascular Diseases

PR Newswire September 3, 2025

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren's disease

PR Newswire August 11, 2025

Novartis twice-yearly* Leqvio® (inclisiran) receives FDA approval for new indication enabling first-line use

PR Newswire July 31, 2025

Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)

PR Newswire July 3, 2025

NYSE Content Advisory: Pre-Market update + Wall Street reopens after Juneteenth

PR Newswire June 20, 2025

Novartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN)

PR Newswire April 2, 2025

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) - the first and only treatment approved in C3 glomerulopathy (C3G)

PR Newswire March 20, 2025

Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU)

PR Newswire February 28, 2025
View More News ››

Opinion & Analysis (NYSE:NVS)

EpiPen Rival Lands Major Partner

Streetwise Reports July 3, 2018

Biotech Round-Up: M&As, Financings and Immuno-Oncology

Streetwise Reports April 19, 2018

Analysts take note as small-cap biotech completes early enrollment for Phase 3 trial

The Life Sciences Report July 6, 2017

Big pharma sets its sights on NASH epidemic

The Life Sciences Report May 18, 2017

Stellar Biotechnologies (SBOT:NASDAQ) could rise with KLH vaccine trial success

The Life Sciences Report March 2, 2017

Partnerships propel Stellar Biotechnologies' vaccine technology

The Life Sciences Report June 22, 2016
View More Opinion ››

Bullboard Posts (NYSE:NVS)

India Oral Hygiene Market Size and Trends 2027

The IMARC Group provides extensive analysis of the India Oral Hygiene industry covering the market trends, investment opportunities...
Imarcgroup - September 14, 2022

RE:RE:IVERMICTIN KILLS COVID 19 !

THE FAUCI INDICTMENT (Video) — SOTN: Alternative News ...   Oct 09, 2021 · THE FAUCI INDICTMENT…...
zeropointenergy - October 16, 2021

RE:IVERMICTIN KILLS COVID 19 !

Dr. Richard Bartlett on Budesonide, the Silver Bullet ... https://www.thethinkingconservative.com/dr-richard...
zeropointenergy - October 9, 2021

IVERMICTIN KILLS COVID 19 !

 NICE China Reports Zero New Locally Acquired Covid-19 Cases for Fourth Day in a Row  
zeropointenergy - October 9, 2021

ONE DRUG PILL WIPES OUT COVID 19!

India's Ivermectin Blackout - Part V: The Secret Revealed ...   Sep 27, 2021 · By September 12, 2021...
zeropointenergy - October 6, 2021

looking for pharma partner- Amazing-

  9:33NOW PLAYING
goodheart-r - January 25, 2021
View more Bullboard ››

AE Fuels Corporation

AE Fuels Corporation

AE Fuels Corporation (TSXV: AEF) is a battery materials company focused on the extraction and purification of minerals ...
View More »

Podcasts